Synovus Financial’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $16.8M | Buy |
59,438
+524
| +0.9% | +$152K | 0.19% | 79 |
|
|
2025
Q2 | $16.5M | Buy |
58,914
+818
| +1% | +$232K | 0.2% | 73 |
|
|
2025
Q1 | $18.1M | Sell |
58,096
-7,633
| -12% | -$2.25M | 0.23% | 64 |
|
|
2024
Q4 | $17.1M | Buy |
65,729
+165
| +0.3% | +$49K | 0.22% | 67 |
|
|
2024
Q3 | $21.1M | Buy |
65,564
+2,046
| +3% | +$669K | 0.24% | 62 |
|
|
2024
Q2 | $19.8M | Buy |
63,518
+531
| +0.8% | +$156K | 0.26% | 57 |
|
|
2024
Q1 | $17.9M | Buy |
62,987
+2,693
| +4% | +$788K | 0.23% | 63 |
|
|
2023
Q4 | $17.4M | Sell |
60,294
-7,945
| -12% | -$2.16M | 0.25% | 61 |
|
|
2023
Q3 | $18.3M | Buy |
68,239
+1,008
| +1% | +$252K | 0.21% | 79 |
|
|
2023
Q2 | $14.9M | Buy |
67,231
+826
| +1% | +$192K | 0.16% | 97 |
|
|
2023
Q1 | $16.1M | Buy |
66,405
+2,603
| +4% | +$639K | 0.18% | 90 |
|
|
2022
Q4 | $16.8M | Buy |
63,802
+4,602
| +8% | +$1.23M | 0.19% | 84 |
|
|
2022
Q3 | $13.4M | Buy |
59,200
+3,754
| +7% | +$910K | 0.16% | 96 |
|
|
2022
Q2 | $13.5M | Buy |
55,446
+3,680
| +7% | +$902K | 0.16% | 96 |
|
|
2022
Q1 | $12.5M | Buy |
51,766
+571
| +1% | +$131K | 0.13% | 110 |
|
|
2021
Q4 | $11.5M | Buy |
51,195
+5,271
| +11% | +$1.11M | 0.11% | 124 |
|
|
2021
Q3 | $9.77M | Buy |
45,924
+11,006
| +32% | +$2.53M | 0.1% | 128 |
|
|
2021
Q2 | $8.5M | Sell |
34,918
-418
| -1% | -$103K | 0.08% | 138 |
|
|
2021
Q1 | $8.78M | Buy |
35,336
+783
| +2% | +$187K | 0.1% | 127 |
|
|
2020
Q4 | $7.95M | Sell |
34,553
-7,172
| -17% | -$1.65M | 0.09% | 131 |
|
|
2020
Q3 | $10.6M | Sell |
41,725
-1,792
| -4% | -$444K | 0.14% | 102 |
|
|
2020
Q2 | $10.3M | Sell |
43,517
-9,269
| -18% | -$2.11M | 0.15% | 96 |
|
|
2020
Q1 | $10.7M | Buy |
52,786
+5,402
| +11% | +$1.18M | 0.15% | 99 |
|
|
2019
Q4 | $11.4M | Sell |
47,384
-2,212
| -4% | -$488K | 0.16% | 92 |
|
|
2019
Q3 | $9.61M | Buy |
49,596
+1,033
| +2% | +$198K | 0.14% | 96 |
|
|
2019
Q2 | $8.94M | Sell |
48,563
-9,757
| -17% | -$1.75M | 0.13% | 99 |
|
|
2019
Q1 | $11.1M | Sell |
58,320
-1,431
| -2% | -$273K | 0.18% | 87 |
|
|
2018
Q4 | $11.6M | Buy |
59,751
+2,627
| +5% | +$513K | 0.21% | 79 |
|
|
2018
Q3 | $11.8M | Buy |
57,124
+1,157
| +2% | +$228K | 0.19% | 82 |
|
|
2018
Q2 | $10.3M | Buy |
55,967
+1,341
| +2% | +$237K | 0.17% | 88 |
|
|
2018
Q1 | $9.31M | Buy |
54,626
+3,090
| +6% | +$567K | 0.16% | 93 |
|
|
2017
Q4 | $8.96M | Sell |
51,536
-330
| -0.6% | -$58.4K | 0.16% | 91 |
|
|
2017
Q3 | $9.67M | Buy |
51,866
+231
| +0.4% | +$40.9K | 0.18% | 88 |
|
|
2017
Q2 | $8.89M | Sell |
51,635
-1,371
| -3% | -$223K | 0.18% | 87 |
|
|
2017
Q1 | $8.7M | Buy |
53,006
+1,504
| +3% | +$250K | 0.18% | 87 |
|
|
2016
Q4 | $7.53M | Buy |
51,502
+9,538
| +23% | +$1.44M | 0.17% | 89 |
|
|
2016
Q3 | $7.01M | Buy |
41,964
+2,124
| +5% | +$359K | 0.16% | 88 |
|
|
2016
Q2 | $6.07M | Buy |
39,840
+1,056
| +3% | +$164K | 0.14% | 93 |
|
|
2016
Q1 | $5.82M | Buy |
38,784
+2,209
| +6% | +$328K | 0.14% | 95 |
|
|
2015
Q4 | $5.93M | Buy |
36,575
+4,301
| +13% | +$676K | 0.15% | 96 |
|
|
2015
Q3 | $4.46M | Buy |
32,274
+2,401
| +8% | +$378K | 0.12% | 109 |
|
|
2015
Q2 | $4.58M | Sell |
29,873
-1,417
| -5% | -$227K | 0.12% | 117 |
|
|
2015
Q1 | $5M | Buy |
31,290
+2,926
| +10% | +$461K | 0.13% | 108 |
|
|
2014
Q4 | $4.52M | Buy |
28,364
+1,121
| +4% | +$175K | 0.12% | 116 |
|
|
2014
Q3 | $3.82M | Buy |
27,243
+1,959
| +8% | +$256K | 0.11% | 125 |
|
|
2014
Q2 | $2.99M | Buy |
25,284
+520
| +2% | +$60.2K | 0.08% | 132 |
|
|
2014
Q1 | $3.06M | Buy |
24,764
+107
| +0.4% | +$13K | 0.09% | 125 |
|
|
2013
Q4 | $2.82M | Buy |
24,657
+514
| +2% | +$58.5K | 0.08% | 136 |
|
|
2013
Q3 | $2.7M | Buy |
24,143
+13,537
| +128% | +$1.47M | 0.08% | 129 |
|
|
2013
Q2 | $1.05M | Buy |
+10,606
| New | +$1.1M | 0.03% | 227 |
|
Other funds holding AMGN
Synovus Financial's AMGN Position: Q3 2025 in Review
Synovus Financial increased its Amgen (AMGN) stake by 0.89% in Q3 2025, buying an estimated $152K and bringing the position to 59,438 shares worth $16.8M. The position accounts for 0.19% of the portfolio, ranked #79.
Synovus Financial first reported a position in AMGN in Q2 2013 and has held it in 50 quarters since. The position peaked at $21.1M in Q3 2024. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.
- Synovus Financial held 59,438 shares of Amgen worth $16.8M as of Q3 2025.
- Synovus Financial bought 524 Amgen shares in Q3 2025, an estimated $152K.
- Amgen made up 0.19% of Synovus Financial's portfolio in Q3 2025, its #79 holding.
- Synovus Financial first reported a position in Amgen in Q2 2013 and has held it in 50 quarters since.
- Synovus Financial's Amgen position peaked at $21.1M in Q3 2024.
- 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.
Based on Synovus Financial's 13F filing for Q3 2025, filed 7 Nov 2025.